Immuno-Oncology Screening Library

For screening a variety of immuno-oncology associated compounds; contains more than 90 cancer and immunology-associated compounds as 10 mM stock solutions in DMSO; includes a variety of immuno-oncology target modulators, including but not limited to, adenosine, CCR, CXCR, and TLR agonists and antagonists, BTK, PI3K, and BRAF inhibitors, PD-1/PDL-1 interaction inhibitors, and HDAC inhibitors